References
- Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized, double blind study. J Infect Dis 1995; 171: 1545–1552.
- Redding SW, Kirkpatrick WR, Coco BJ, et al. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treat-ment for head and neck cancer. J Clin Microbiol 2002; 40: 1879–1881.
- Thuraisingham Al, Denning DW. Candida glabrata esophagitis in a patient without HIV infection. Eur J Clin Microbiol Infect Dis 2000; 19: 561–562.
- Gumbo T, Isada CM, Hall G, et al. Candida glabrata fungemia. Clinical features of 139 patients. Medicine 1999; 78: 220–227.
- Marr KA, Seidel K, White TC, et al. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181: 309–316.
- Doebbling BN, Lehmenn RF, Hollis RJ, et al. Comparison of pulsed-field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis. Clin Infect Dis 1993; 16: 377–383.
- Magee PT, Bowdin L, Staudinger J. Comparison of molecular typing methods for Candida albicans. J Gun Microbiol 1992; 30: 2674–2679.
- Di Francesco L, Barchiesi F, Caselli F, Cirioni 0, Scalise G. Comparison of four methods for DNA typing of clinical isolates of Candida glabrata. J Med Microbiol 1999; 48: 955–963.
- Barchiesi F, Di Francesco L, Arzeni D, et al. Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates. Eur J Microbiol Infect Dis 1999; 18: 184–187.
- Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis 2001; 33: 1959-1967.